EFEarnings Feed

Filing detail

6-KTicker NRSNCIK 0001875091

NeuroSense Therapeutics Ltd. 6-K

Accession 0001213900-25-113300

Filed Nov 20, 7:00 PM ETAccepted Nov 21, 6:36 AM ETSize 3.7 MB
View on sec.gov ↗Open company profile

Filed (ET)

Nov 20, 7:00 PM ET

Accepted

Nov 21, 6:36 AM ET

File size

3.7 MB

SEC accession

0001213900-25-113300

Filing details

Company
NeuroSense Therapeutics Ltd.
CIK
0001875091
Incorporated
Israel
Entity type
other

Related parties

  • filerCIK 0001875091

Documents

Attached files
7 items

  • ea0266625-6k_neuro.htm

    6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PrimaryOpen file ↗

  • ea026662501ex99-1_neuro.htm

    EX-99.1

    NOTICE AND PROXY STATEMENT FOR THE SPECIAL MEETING OF SHAREHOLDERS OF THE REGISTRANT SCHEDULED FOR DECEMBER 30, 2025

    Open file ↗

  • ea026662501ex99-2_neuro.htm

    EX-99.2

    PROXY CARD

    Open file ↗

  • tneurosense_logo.jpg

    GRAPHIC

    GRAPHIC

    Open file ↗

  • tneurosense_logo1.jpg

    GRAPHIC

    GRAPHIC

    Open file ↗

  • tproxy_001.jpg

    GRAPHIC

    GRAPHIC

    Open file ↗

  • tproxy_002.jpg

    GRAPHIC

    GRAPHIC

    Open file ↗